FDA
-
-
-
-
-
-
-
Acurx Announces Scientific Poster Presentation of its DNA pol IIIC Inhibitors' Microbiome Evaluation at ESCMID Global 2026
-
-
-
-
-
-
-
Acurx Pharmaceuticals raises $2.5 million in registered direct offering
-
-
-
-
-
-
-
USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
-
-
-
-
-
-
-
Acurx receives Australian patent for DNA polymerase IIIC inhibitors
-
-
-
-
-
-
-
Acurx Pharmaceuticals, Inc. Reports Second Quarter Results and Provides Business Update
-
-
-
-
-
-
-
Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Federation of American Societies for Exp
-
-
-
-
-
-
-
Acurx Pharmaceuticals, Inc. Announces Closing of $1.1 Million Registered Direct Offering
-
325,889 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

